These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. [Circumventing resistance to imatinib therapy in chronic myeloid leukemia]. Minami Y; Naoe T Gan To Kagaku Ryoho; 2009 Apr; 36(4):544-7. PubMed ID: 19381024 [TBL] [Abstract][Full Text] [Related]
11. On the offensive. Abbott A Nature; 2002 Apr; 416(6880):470-4. PubMed ID: 11932714 [No Abstract] [Full Text] [Related]
12. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Engelman JA; Settleman J Curr Opin Genet Dev; 2008 Feb; 18(1):73-9. PubMed ID: 18325754 [TBL] [Abstract][Full Text] [Related]
13. Concomitant t(3;3)(q21;q26), trisomy 19, and E255V mutation associated with imatinib mesylate resistance in chronic myelogenous leukemia. Park TS; Cheong JW; Kim SJ; Lee KW; Song J; Lee KA; Suh B; Song S; Choi JR Cancer Genet Cytogenet; 2009 Apr; 190(1):46-8. PubMed ID: 19264234 [No Abstract] [Full Text] [Related]
14. Resistance and relapse with imatinib in CML: causes and consequences. Deininger M J Natl Compr Canc Netw; 2008 Mar; 6 Suppl 2():S11-S21. PubMed ID: 18397677 [TBL] [Abstract][Full Text] [Related]
15. [Pharmazie in unserer Zeit 5/2008]. Dingermann T; Laufer S; Winckler T Pharm Unserer Zeit; 2008; 37(5):349. PubMed ID: 18729281 [No Abstract] [Full Text] [Related]
16. Unexplored pharmacokinetic opportunities with microdosing in oncology. Sparreboom A Clin Cancer Res; 2007 Jul; 13(14):4033-4. PubMed ID: 17634525 [No Abstract] [Full Text] [Related]
17. Proteomic analysis of an imatinib-resistant K562 cell line highlights opposing roles of heat shock cognate 70 and heat shock 70 proteins in resistance. Pocaly M; Lagarde V; Etienne G; Dupouy M; Lapaillerie D; Claverol S; Vilain S; Bonneu M; Turcq B; Mahon FX; Pasquet JM Proteomics; 2008 Jun; 8(12):2394-406. PubMed ID: 18563733 [TBL] [Abstract][Full Text] [Related]
18. Advances in molecular targets and cancer therapeutics. Westwell AD Drug Discov Today; 2004 Mar; 9(5):207-9. PubMed ID: 14980538 [No Abstract] [Full Text] [Related]
19. Cancer therapy: new drugs are emerging based on molecular targeting but still many challenges. Altucci L; Balducci L; Irminger-Finger I Int J Biochem Cell Biol; 2007; 39(7-8):1278-9. PubMed ID: 17548227 [No Abstract] [Full Text] [Related]
20. Catastrophic tumour lysis syndrome following single dose of imatinib. Keane C; Henden A; Bird R Eur J Haematol; 2009 Mar; 82(3):244-5. PubMed ID: 19067739 [No Abstract] [Full Text] [Related] [Next] [New Search]